Vaginal Slings Market By Type (Conventional Vaginal Slings, Advanced Vaginal Slings), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Description

List of Tables

The global vaginal slings market was valued at $1,074.8 million in 2020, and is projected to reach $3,302.5 million by 2030, registering a CAGR of 12.4% from 2021 to 2030. In women, stress urinary incontinence is known to be a social disease that can be caused by various contributing factors, such as natural childbirth, obesity, hormonal deficiencies, and changes in collagen fibers. Vaginal slings are incorporated in the surgical procedures used to treat stress urinary incontinence in women, using different types of vaginal slings, such as synthetic slings, natural slings, and single-incision slings. The key factors that drive the market growth include, rise in the incidence of stress urinary incontinence and increase in the female geriatric population. In addition, keen interest of market players in the development of materially advanced vaginal slings and rise in the demand for single-incision vaginal slings supplement the market growth.

The vaginal slings market is segmented on the basis of type, end user, and region. By type, the market is classified into conventional vaginal slings and advanced vaginal slings. On the basis of end user, it is classified into hospitals, clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major companies profiled in this report include A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Coloplast, Cousin Biotech, Caldera Medical Medtronic PLC, Neomedic International, and Promedon Group.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the antibacterial coatings market analysis from 2020 to 2030 to identify the prevailing antibacterial coatings market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the antibacterial coatings market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global antibacterial coatings market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Conventional Vaginal Slings
Advanced Vaginal Slings

By End User

Hospitals
Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- Australia
- India
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- A.M.I. GmbH
- B. BRAUN MELSUNGEN AG
- Betatech Medical
- Boston Scientific Corporation
- coloplast
- cousin biotech
- Caldera Medical
- Medtronic plc
- neomedic international
- Promedon Group

Product Code: A04168

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: VAGINAL SLINGS MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Conventional Vaginal Slings
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Advanced Vaginal Slings
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: VAGINAL SLINGS MARKET, BY END USER

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Hospitals
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Clinics
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: VAGINAL SLINGS MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Type
- 6.2.3 North America Market size and forecast, by End User
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Market size and forecast, by Type
  - 6.2.4.1.2 Market size and forecast, by End User
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Market size and forecast, by Type
  - 6.2.4.2.2 Market size and forecast, by End User
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Market size and forecast, by Type
  - 6.2.4.3.2 Market size and forecast, by End User
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Type
- 6.3.3 Europe Market size and forecast, by End User
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Market size and forecast, by Type
  - 6.3.4.1.2 Market size and forecast, by End User
  - 6.3.4.2 France
  - 6.3.4.2.1 Market size and forecast, by Type
  - 6.3.4.2.2 Market size and forecast, by End User
  - 6.3.4.3 United Kingdom
  - 6.3.4.3.1 Market size and forecast, by Type
  - 6.3.4.3.2 Market size and forecast, by End User
  - 6.3.4.4 Italy
  - 6.3.4.4.1 Market size and forecast, by Type
  - 6.3.4.4.2 Market size and forecast, by End User
  - 6.3.4.5 Spain
  - 6.3.4.5.1 Market size and forecast, by Type
  - 6.3.4.5.2 Market size and forecast, by End User
  - 6.3.4.6 Rest of Europe
  - 6.3.4.6.1 Market size and forecast, by Type
  - 6.3.4.6.2 Market size and forecast, by End User
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Type
- 6.4.3 Asia-Pacific Market size and forecast, by End User
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 China
  - 6.4.4.1.1 Market size and forecast, by Type
  - 6.4.4.1.2 Market size and forecast, by End User
  - 6.4.4.2 Japan
  - 6.4.4.2.1 Market size and forecast, by Type
  - 6.4.4.2.2 Market size and forecast, by End User
  - 6.4.4.3 Australia
  - 6.4.4.3.1 Market size and forecast, by Type
  - 6.4.4.3.2 Market size and forecast, by End User
  - 6.4.4.4 India
  - 6.4.4.4.1 Market size and forecast, by Type
  - 6.4.4.4.2 Market size and forecast, by End User
  - 6.4.4.5 Rest of Asia-Pacific
  - 6.4.4.5.1 Market size and forecast, by Type
  - 6.4.4.5.2 Market size and forecast, by End User
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Type
- 6.5.3 LAMEA Market size and forecast, by End User
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Brazil
  - 6.5.4.1.1 Market size and forecast, by Type
  - 6.5.4.1.2 Market size and forecast, by End User
  - 6.5.4.2 Turkey
  - 6.5.4.2.1 Market size and forecast, by Type
  - 6.5.4.2.2 Market size and forecast, by End User
  - 6.5.4.3 Saudi Arabia
  - 6.5.4.3.1 Market size and forecast, by Type
  - 6.5.4.3.2 Market size and forecast, by End User
  - 6.5.4.4 South Africa
  - 6.5.4.4.1 Market size and forecast, by Type
  - 6.5.4.4.2 Market size and forecast, by End User
  - 6.5.4.5 Rest of LAMEA
  - 6.5.4.5.1 Market size and forecast, by Type
  - 6.5.4.5.2 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments

CHAPTER 8: COMPANY PROFILES

8.1 A.M.I. GmbH
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
8.2 B. BRAUN MELSUNGEN AG
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
8.3 Betatech Medical
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
8.4 Boston Scientific Corporation
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
8.5 coloplast
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
8.6 cousin biotech
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
8.7 Caldera Medical
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
8.8 Medtronic plc
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
8.9 neomedic international
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
8.10 Promedon Group
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments